Literature DB >> 18830382

Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis.

Eldad A Hod1, Set A Sokol, James C Zimring, Steven L Spitalnik.   

Abstract

Classical anaphylaxis is the most severe, and potentially fatal, type of allergic reaction, manifested by hypotension, bronchoconstriction, and vascular permeability. Similarly, a hemolytic transfusion reaction (HTR) is the most feared consequence of blood transfusion. Evidence for the existence of an alternative, IgG-mediated pathway of anaphylaxis may be relevant for explaining the pathophysiology of IgG-mediated-HTRs. The purpose of this review is to summarize the evidence for this alternative pathway of anaphylaxis and to present the hypothesis that an IgG-mediated HTR is one example of this type of anaphylaxis.

Entities:  

Keywords:  anaphylaxis; hemolytic transfusion reaction; platelet activating factor

Year:  2008        PMID: 18830382      PMCID: PMC2491388     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  89 in total

1.  Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.

Authors:  A A Pineda; E C Vamvakas; L D Gorden; J L Winters; S B Moore
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

2.  Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.

Authors:  J W Semple; D Allen; M Rutherford; M Woloski; M David; C Wakefield; S Butchart; J Freedman; V Blanchette
Journal:  Am J Hematol       Date:  2002-03       Impact factor: 10.047

3.  Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria.

Authors:  D Bratosin; J Estaquier; F Petit; D Arnoult; B Quatannens; J P Tissier; C Slomianny; C Sartiaux; C Alonso; J J Huart; J Montreuil; J C Ameisen
Journal:  Cell Death Differ       Date:  2001-12       Impact factor: 15.828

4.  [Fatal delayed hemolytic transfusion reaction in a postoperative case of traumatic aortic rupture].

Authors:  O Shigeta; S Akishima; Y Watanabe; N Hasegawa; H Unno; Y Sakakibara; H Ijima; T Tsutsui; K Okamura; T Mitsui
Journal:  Kyobu Geka       Date:  1990-06

Review 5.  Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment.

Authors:  S M Capon; D Goldfinger
Journal:  Transfusion       Date:  1995-06       Impact factor: 3.157

6.  Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.

Authors:  R Rabinovici; T L Yue; M Farhat; E F Smith; K M Esser; M Slivjak; G Feuerstein
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

7.  Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.

Authors:  D Dombrowicz; V Flamand; I Miyajima; J V Ravetch; S J Galli; J P Kinet
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Authors:  A Svetić; F D Finkelman; Y C Jian; C W Dieffenbach; D E Scott; K F McCarthy; A D Steinberg; W C Gause
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.

Authors:  D M Stafforini; K Satoh; D L Atkinson; L W Tjoelker; C Eberhardt; H Yoshida; T Imaizumi; S Takamatsu; G A Zimmerman; T M McIntyre; P W Gray; S M Prescott
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

10.  Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention.

Authors:  L D Butler; N K Layman; R L Cain; P E Riedl; K M Mohler; J L Bobbitt; R Belagajie; J Sharp; A M Bendele
Journal:  Clin Immunol Immunopathol       Date:  1989-12
View more
  2 in total

1.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

2.  Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration.

Authors:  Giovanna Cannas; Léa Dubreuil; Axel Fichez; Mathieu Gerfaud-Valentin; Anne-Lise Debard; Arnaud Hot
Journal:  Am J Case Rep       Date:  2021-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.